These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16641790)

  • 21. Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
    Wang DC; Jang HJ; Kim TK
    AJR Am J Roentgenol; 2020 Jun; 214(6):1295-1304. PubMed ID: 32182094
    [No Abstract]   [Full Text] [Related]  

  • 22. Contrast-Enhanced Ultrasound of Focal Liver Masses: A Success Story.
    Wilson SR; Burns PN; Kono Y
    Ultrasound Med Biol; 2020 May; 46(5):1059-1070. PubMed ID: 32059917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].
    Gómez Rodríguez RA; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; Repiso Ortega A; Pérez-Grueso Macías MJ; Muñoz Rosas C; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2007; 30(7):381-6. PubMed ID: 17692194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging of focal liver lesions.
    Jang HJ; Yu H; Kim TK
    Semin Roentgenol; 2009 Oct; 44(4):266-82. PubMed ID: 19715792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
    Burns PN; Wilson SR
    Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Improved detection and characterisation of liver tumors with echo-enhanced ultrasound].
    Schuessler G; Ignee A; Hirche T; Dietrich CF
    Z Gastroenterol; 2003 Dec; 41(12):1167-76. PubMed ID: 14661127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
    Oldenburg A; Albrecht T
    Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of focal liver lesions with contrast enhanced ultrasonography.
    Dietrich CF
    Eur J Radiol; 2004 Jun; 51 Suppl():S9-17. PubMed ID: 15234021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time contrast-enhanced ultrasound imaging of focal liver lesions in fatty liver.
    Liu GJ; Wang W; Xie XY; Xu HX; Xu ZF; Zheng YL; Liang JY; Moriyasu F; Lu MD
    Clin Imaging; 2010; 34(3):211-21. PubMed ID: 20416486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
    Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
    Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases.
    Dong Y; Zhang XL; Mao F; Huang BJ; Si Q; Wang WP
    Scand J Gastroenterol; 2017 Jan; 52(1):23-28. PubMed ID: 27577113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and characterisation of liver metastases.
    Albrecht T; Hohmann J; Oldenburg A; Skrok J; Wolf KJ
    Eur Radiol; 2004 Oct; 14 Suppl 8():P25-33. PubMed ID: 15700330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents.
    Hohmann J; Albrecht T; Hoffmann CW; Wolf KJ
    Eur J Radiol; 2003 May; 46(2):147-59. PubMed ID: 12714231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contrast-enhanced ultrasound in the diagnosis of benign and malignant hepatic tumors].
    Jiang Y; Zhou Q; Zhu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):53-6. PubMed ID: 22349380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.